---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-24-000017"
form_type: "8-K/A"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:49:24.833275+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q1 revenue up 12.5% to $248M; net income $6M; reaffirms 2024 outlook

## Summary
- Q1 net revenues $248M (+12.5% YoY); net income $6M ($0.02 diluted EPS) vs $3M ($0.01) in Q1 2023.
- Adjusted EBITDA $112M (+13.7% YoY); Adjusted EPS $0.13 flat YoY.
- Sterigenics segment net revenues $166M (+4.1%), segment income $86M (+3.6%).
- Co reaffirms 2024 outlook; cites EPA finalizing updated NESHAP for ethylene oxide as manageable.
- 8-K/A filed to correct typo in prior exhibit; no impact on reported income metrics.

## SEC filing metadata
- accession: 0001822479-24-000017
- form_type: 8-K/A
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000017/0001822479-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000017/shc-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-24-000017
- JSON: https://secwatch.observer/filing/0001822479-24-000017.json
- Plain text: https://secwatch.observer/filing/0001822479-24-000017.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported the three months ended March 31, 2024 results: revenue $248 million, net income $6 million, EPS $0.02 per diluted share. Guidance reaffirmed.
  - Period: the three months ended March 31, 2024
  - Revenue: $248 million
  - Net income: $6 million
  - EPS: $0.02 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: First-quarter 2024 net revenues increased 12.5% to $248 million, compared to $221 million in the first-quarter 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000017/0001822479-24-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.